AZBio Trailblazers are selected annually and recognized for their leadership in supporting research, education, innovation and the growth of Arizona’s bioscience sector by the Arizona Bioindustry Association.Continue reading
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.Continue reading
Steve Ubl, president and CEO of AdvaMed will leave his post at AdvaMed in the fall to serve as president and CEO of PhRMA.
Ubl shared the letter below with the AdvaMed Board of Directors on Friday, September 25, 2015.Continue reading
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.
The Safe and Accurate Food Labeling Act will ensure that food labeling in the United States is consistent across state lines and based on sound science. Continue reading
It seems like only yesterday that Congress, the FDA, and industry came together to reauthorize the Medical Device User Fee Agreement (MDUFA III). Now the process begins again as we prepare for MDUFA IV.Continue reading
Bipartisan action on July 14, 2015 by the U.S. House Agriculture Committee advances the Safe and Accurate Food Labeling Act (H.R. 1599).Continue reading
In a 344 to 77 vote, the U.S. House of Representatives passed H.R.6: The 21st Century Cures Act on the morning of July 10, 2015. Continue reading
21st Century Cures passes unanimously out of the House Energy and Commerce Committee.
“AZBio congratulates Members of the House Energy and Commerce Committee and all of the representatives of industry, patients, and our key federal agency partners on a truly collaborative effort to progress H.R. 6 – The 21st Century Cures Act.” Joan Koerber-Walker, President & CEO, Arizona Bioindustry Association (AZBio) and Chair, AdvaMed State Medical Technology Alliance Continue reading